UPC Analytics
ENDE
Overview · Filed: Mar 3, 2025

UPC_CFI_191/2025

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

InfringementMain Infringement ActionThe Hague LDInfringementInterim Phase
  • 2025-05-23Procedural onlyPreliminary objection

    Procedural order from The Hague Local Division dated 23 May 2025 ruling on a preliminary objection raised by Moderna defendants. The court dismissed Moderna's jurisdictional objections concerning Moderna Spain, Moderna Poland, and Moderna Norway, finding that the UPC has international jurisdiction under Art. 8(1) Brussels I Recast (commercial relationship within the same group) and that the LD The Hague has local competence under Art. 33(1)(b) UPCA because Moderna Netherlands B.V. is domiciled in the Netherlands. An opt-out validity issue was also addressed. The decision allows the infringement proceedings to proceed on the merits.